MDM2 and prostate neoplasm: Pencik et al. showed an increased aggressivity of prostate tumors in Ptenpc−/−/Stat3pc−/− mice, with a concomitant deregulation of the senescent state by disrupting the ARF–MDM2–p53 tumor suppressor axis [37].